Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Loxo Oncology Company Profile (NASDAQ:LOXO)

Consensus Ratings for Loxo Oncology (NASDAQ:LOXO) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.75 (74.52% upside)

Analysts' Ratings History for Loxo Oncology (NASDAQ:LOXO)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2015OppenheimerInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015OppenheimerSet Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Leerink SwannInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014OppenheimerInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2014Stifel NicolausInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2014JMP SecuritiesInitiated CoverageOutperform$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)